Stockscreener 앱 받기
30.07
7.53%
-2.45
Hemab Therapeutics Holdings Inc (COAG) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 |
| 기간 | 3개월 | 3개월 |
Operating Expenses
|
10.45%
26.08
|
23.61 |
| Operating Income/Loss |
10.45%
-26.08
|
-23.61 |
| Income/Loss From Continuing Operations Before Tax |
6.08%
-24.05
|
-22.68 |
| Income Tax Expense/Benefit |
708.33%
0.097
|
0.012 |
| Net Income/Loss |
6.45%
-24.15
|
-22.69 |
| Basic Average Shares |
3,083%
30.11
|
0.946 |
| Diluted Average Shares |
3,083%
30.11
|
0.946 |
| Basic Earnings Per Share |
96.66%
-0.80
|
-23.98 |
| Diluted Earnings Per Share |
96.66%
-0.80
|
-23.98 |
7.09%
4.63%
자본화:
|
볼륨(24시간):